Search research articles
Contact Us
Filters
Showing results (441-450 of 482) with videos related to
Page
of 49
Sort By:
Techniques in Coloproctology
|
June 12, 2008
Anastomotic leaks after anterior resection for mid and low rectal cancer: survey of the Italian Society of Colorectal Surgery
C R Asteria, G Gagliardi, S Pucciarelli, et al.
Annals of Neurology
|
March 13, 2008
A phase I/IItrial of MYO-029 in adult subjects with muscular dystrophy
Kathryn R Wagner, James L Fleckenstein, Anthony A Amato, et al.
The Lancet. Neurology
|
September 22, 2023
Safety and efficacy of arimoclomol for inclusion body myositis: a multicentre, randomised, double-blind, placebo-controlled trial
Pedro M Machado, Michael P McDermott, Thomas Blaettler, et al.
Brain : a Journal of Neurology
|
October 29, 2014
Novel mutations in human and mouse SCN4A implicate AMPK in myotonia and periodic paralysis
Silvia Corrochano, Roope Männikkö, Peter I Joyce, et al.
Annals of the Rheumatic Diseases
|
April 8, 2017
2016 American College of Rheumatology/European League Against Rheumatism criteria for minimal, moderate, and major clinical response in adult dermatomyositis and polymyositis: An International Myositis Assessment and Clinical Studies Group/Paediatric Rheumatology International Trials Organisation Collaborative Initiative
Rohit Aggarwal, Lisa G Rider, Nicolino Ruperto, et al.
Arthritis & Rheumatology (Hoboken, N.J.)
|
April 7, 2017
2016 American College of Rheumatology/European League Against Rheumatism Criteria for Minimal, Moderate, and Major Clinical Response in Adult Dermatomyositis and Polymyositis: An International Myositis Assessment and Clinical Studies Group/Paediatric Rheumatology International Trials Organisation Collaborative Initiative
Rohit Aggarwal, Lisa G Rider, Nicolino Ruperto, et al.
Muscle & Nerve
|
April 16, 2022
Randomized phase 2 study of ACE-083, a muscle-promoting agent, in facioscapulohumeral muscular dystrophy
Jeffrey M Statland, Craig Campbell, Urvi Desai, et al.
The Journal of Biological Chemistry
|
May 16, 2012
GQ-16, a novel peroxisome proliferator-activated receptor γ (PPARγ) ligand, promotes insulin sensitization without weight gain
Angélica A Amato, Senapathy Rajagopalan, Jean Z Lin, et al.
Neurology
|
December 3, 2021
Phase 2 Trial of Rituximab in Acetylcholine Receptor Antibody-Positive Generalized Myasthenia Gravis: The BeatMG Study
Richard J Nowak, Christopher S Coffey, Jonathan M Goldstein, et al.
Rheumatology (Oxford, England)
|
October 5, 2017
2016 ACR-EULAR adult dermatomyositis and polymyositis and juvenile dermatomyositis response criteria-methodological aspects
Lisa G Rider, Nicolino Ruperto, Angela Pistorio, et al.
Page
of 49
Search research articles
Search
Showing results (441-450 of 482) with videos related to
Sort By:
Page
of 49
Techniques in Coloproctology
|
June 12, 2008
Anastomotic leaks after anterior resection for mid and low rectal cancer: survey of the Italian Society of Colorectal Surgery
C R Asteria, G Gagliardi, S Pucciarelli, et al.
Annals of Neurology
|
March 13, 2008
A phase I/IItrial of MYO-029 in adult subjects with muscular dystrophy
Kathryn R Wagner, James L Fleckenstein, Anthony A Amato, et al.
The Lancet. Neurology
|
September 22, 2023
Safety and efficacy of arimoclomol for inclusion body myositis: a multicentre, randomised, double-blind, placebo-controlled trial
Pedro M Machado, Michael P McDermott, Thomas Blaettler, et al.
Brain : a Journal of Neurology
|
October 29, 2014
Novel mutations in human and mouse SCN4A implicate AMPK in myotonia and periodic paralysis
Silvia Corrochano, Roope Männikkö, Peter I Joyce, et al.
Annals of the Rheumatic Diseases
|
April 8, 2017
2016 American College of Rheumatology/European League Against Rheumatism criteria for minimal, moderate, and major clinical response in adult dermatomyositis and polymyositis: An International Myositis Assessment and Clinical Studies Group/Paediatric Rheumatology International Trials Organisation Collaborative Initiative
Rohit Aggarwal, Lisa G Rider, Nicolino Ruperto, et al.
Arthritis & Rheumatology (Hoboken, N.J.)
|
April 7, 2017
2016 American College of Rheumatology/European League Against Rheumatism Criteria for Minimal, Moderate, and Major Clinical Response in Adult Dermatomyositis and Polymyositis: An International Myositis Assessment and Clinical Studies Group/Paediatric Rheumatology International Trials Organisation Collaborative Initiative
Rohit Aggarwal, Lisa G Rider, Nicolino Ruperto, et al.
Muscle & Nerve
|
April 16, 2022
Randomized phase 2 study of ACE-083, a muscle-promoting agent, in facioscapulohumeral muscular dystrophy
Jeffrey M Statland, Craig Campbell, Urvi Desai, et al.
The Journal of Biological Chemistry
|
May 16, 2012
GQ-16, a novel peroxisome proliferator-activated receptor γ (PPARγ) ligand, promotes insulin sensitization without weight gain
Angélica A Amato, Senapathy Rajagopalan, Jean Z Lin, et al.
Neurology
|
December 3, 2021
Phase 2 Trial of Rituximab in Acetylcholine Receptor Antibody-Positive Generalized Myasthenia Gravis: The BeatMG Study
Richard J Nowak, Christopher S Coffey, Jonathan M Goldstein, et al.
Rheumatology (Oxford, England)
|
October 5, 2017
2016 ACR-EULAR adult dermatomyositis and polymyositis and juvenile dermatomyositis response criteria-methodological aspects
Lisa G Rider, Nicolino Ruperto, Angela Pistorio, et al.
Page
of 49